← Evidence map

ArticleJournal of controlled release : official journal of the Controlled Release Society2018

Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.

Caslin A Gilroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29551712